A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate how the body absorbs and processes the sustained
release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are
1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls
will also be enrolled based on a matching criteria to post gastric bypass subjects.
Participants will be asked to complete two 12-hour study days approximately 11 days apart.
Phase:
Phase 4
Details
Lead Sponsor:
North Dakota State University
Collaborator:
Neuropsychiatric Research Institute, Fargo, North Dakota